Published in Neuroimage on August 11, 2005
Emotional response deficits in schizophrenia: insights from affective science. Schizophr Bull (2008) 2.90
Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull (2008) 2.77
Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophr Bull (2010) 2.01
Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology (2008) 1.64
Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biol Psychiatry (2009) 1.55
Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study. Schizophr Res (2013) 1.08
Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull (2013) 1.04
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res (2008) 0.97
The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol (2014) 0.96
Olfactory identification and preference in bipolar disorder and schizophrenia. Eur Arch Psychiatry Clin Neurosci (2010) 0.92
Identification of pleasant, neutral, and unpleasant odors in schizophrenia. Psychiatry Res (2011) 0.87
Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients. Schizophr Bull (2011) 0.83
Neural Basis of Anhedonia and Amotivation in Patients with Schizophrenia: The Role of Reward System. Curr Neuropharmacol (2015) 0.80
Olfactory processing in adults with autism spectrum disorders. Mol Autism (2016) 0.79
Motivational Deficits in Schizophrenia and the Representation of Expected Value. Curr Top Behav Neurosci (2016) 0.78
Reduced model-based decision-making in schizophrenia. J Abnorm Psychol (2016) 0.77
The Evaluation of Olfactory Function in Patients With Schizophrenia. Glob J Health Sci (2015) 0.76
Odor naming and interpretation performance in 881 schizophrenia subjects: association with clinical parameters. BMC Psychiatry (2013) 0.76
Altered Basal Ganglia Network Integration in Schizophrenia. Front Hum Neurosci (2015) 0.75
Cortical metabolic arrangement during olfactory processing: proposal for a 18F FDG PET/CT methodological approach. Medicine (Baltimore) (2014) 0.75
Olfactory function in psychotic disorders: Insights from neuroimaging studies. World J Psychiatry (2015) 0.75
Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry (2012) 2.31
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry (2005) 1.78
Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers. World J Biol Psychiatry (2009) 1.64
Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia. J Clin Psychopharmacol (2013) 1.48
Neural correlates of action attribution in schizophrenia. Psychiatry Res (2004) 1.20
Effects of emotion and identity on facial affect processing in schizophrenia. Psychiatry Res (2005) 1.14
Emotion recognition and genetic vulnerability to schizophrenia. Br J Psychiatry (2007) 1.12
A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. Schizophr Res (2010) 1.01
How can cognitive remediation therapy modulate brain activations in schizophrenia? An fMRI study. Psychiatry Res (2011) 1.01
Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res (2005) 0.99
Ratings of different olfactory judgements in schizophrenia. Chem Senses (2002) 0.96
Facial expression and sex recognition in schizophrenia and depression. Can J Psychiatry (2005) 0.95
Attention, motor control and motor imagery in schizophrenia: implications for the role of the parietal cortex. Schizophr Res (2004) 0.95
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls. Schizophr Res (2007) 0.93
Is rTMS efficient as a maintenance treatment for auditory verbal hallucinations? A case report. Schizophr Res (2006) 0.93
A comparison of facial emotion processing in neurological and psychiatric conditions. Front Psychol (2012) 0.92
Source monitoring deficits in hallucinating compared to non-hallucinating patients with schizophrenia. Eur Psychiatry (2006) 0.90
Impaired verbal source monitoring in schizophrenia: an intermediate trait vulnerability marker? Schizophr Res (2006) 0.88
Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Res (2002) 0.88
Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia. Schizophr Res (2002) 0.87
Involvement of right piriform cortex in olfactory familiarity judgments. Neuroimage (2004) 0.86
Exploring imagined movements in patients with schizophrenia. Neuroreport (2002) 0.84
Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiatry Res (2010) 0.84
Thalamus abnormalities during working memory in schizophrenia. An fMRI study. Schizophr Res (2010) 0.84
Efficacy and safety of bifocal tDCS as an interventional treatment for refractory schizophrenia. Brain Stimul (2011) 0.84
Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia. Psychiatry Res (2009) 0.84
Pseudoneglect in schizophrenia: a line bisection study with cueing. Cogn Neuropsychiatry (2007) 0.83
Maintenance treatment with transcranial magnetic stimulation in a patient with late-onset schizophrenia. Am J Psychiatry (2008) 0.83
Exaggerated leftward bias in the mental number line of patients with schizophrenia. Brain Cogn (2006) 0.83
Visual-perceptual abilities in healthy controls, depressed patients, and schizophrenia patients. Brain Cogn (2007) 0.82
A case report of cTBS for the treatment of auditory hallucinations in a patient with schizophrenia. Brain Stimul (2009) 0.81
N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia. Front Psychiatry (2013) 0.80
Reduced expression of STOP/MAP6 in mice leads to cognitive deficits. Schizophr Bull (2012) 0.80
Longitudinal MRI monitoring of brain damage in the neonatal ventral hippocampal lesion rat model of schizophrenia. Hippocampus (2010) 0.80
In the eye of the beholder: individual differences in reward-drive modulate early frontocentral ERPs to angry faces. Neuropsychologia (2008) 0.79
Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse (2007) 0.79
Finding centre: ocular and fMRI investigations of bisection and landmark task performance. Brain Res (2011) 0.79
Visuospatial processing in schizophrenia: does it share common mechanisms with pseudoneglect? Laterality (2011) 0.78
Serotonergic response to stress: a protective factor against abnormal dopaminergic reactivity in schizophrenia? Eur Psychiatry (2007) 0.78
Disrupting pre-SMA activity impairs facial happiness recognition: an event-related TMS study. Cereb Cortex (2012) 0.78
Gaze direction determination in schizophrenia. Schizophr Res (2002) 0.78
Low- vs High-Frequency Repetitive Transcranial Magnetic Stimulation as an Add-On Treatment for Refractory Depression. Front Psychiatry (2012) 0.77
Effects of theta burst stimulation on glutamate levels in a patient with negative symptoms of schizophrenia. Schizophr Res (2009) 0.77
Left temporoparietal transcranial magnetic stimulation in treatment-resistant schizophrenia with verbal hallucinations. Psychiatry Res (2003) 0.77
[Wiscosin card sorting task in patients with schizophrenia and thier siblings]. Can J Psychiatry (2006) 0.77
5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: a pilot [¹⁸F]MPPF positron emission tomography study. Psychiatry Res (2012) 0.76
Summer birth and deficit schizophrenia in Tunisia. Psychiatry Res (2007) 0.76
Theta burst stimulation in the negative symptoms of schizophrenia and striatal dopamine release. An iTBS-[11C]raclopride PET case study. Schizophr Res (2011) 0.76
Persistent auditory hallucinations in out-patients with schizophrenia. Tunis Med (2016) 0.75
Successful switch to maintenance rTMS after maintenance ECT in refractory bipolar disorder. Brain Stimul (2010) 0.75
[Validation of the French version of the Raine schizotypal personality questionnaire in a population of Tunisian students]. Tunis Med (2003) 0.75
Left auditory cortex dysfunction in hallucinating patients with schizophrenia: an MEG study. Clin Neurophysiol (2012) 0.75
Abnormalities of auditory event-related potentials in students with high scores on the Schizotypal Personality Questionnaire. Psychiatry Res (2006) 0.75